OrthoPediatrics Reaffirms 2024 Revenue Guidance Of $200M-$203M
Portfolio Pulse from Benzinga Newsdesk
OrthoPediatrics has reaffirmed its 2024 revenue guidance, projecting revenues between $200 million and $203 million.
August 05, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OrthoPediatrics has reaffirmed its 2024 revenue guidance, projecting revenues between $200 million and $203 million.
Reaffirming revenue guidance is a positive signal to investors, indicating confidence in the company's financial performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100